A Cost-effectiveness Study of Intravenous Immunoglobulin in Childhood Idiopathic Thrombocytopenia Purpura Patients with Life-Threatening Bleeding

被引：0
|
作者：
Rosarin Sruamsiri
Piyameth Dilokthornsakul
Chayanin Pratoomsoot
Nathorn Chaiyakunapruk
机构：
[1] Naresuan University,Department of Pharmacy Practice, Faculty of Pharmaceutical Sciences, Center of Pharmaceutical Outcomes Research
[2] Naresuan University,Faculty of Public Health
[3] Monash University Malaysia,School of Pharmacy
[4] University of Queensland,School of Population Health
[5] University of Wisconsin-Madison,School of Pharmacy
来源：
PharmacoEconomics | 2014年 / 32卷
关键词：
Health Technology Assessment; Direct Medical Cost; Platelet Transfusion; Hospital Database; Supplementary Appendix;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：801 / 813
页数：12
相关论文
共 50 条
  • [1] A Cost-effectiveness Study of Intravenous Immunoglobulin in Childhood Idiopathic Thrombocytopenia Purpura Patients with Life-Threatening Bleeding
    Sruamsiri, Rosarin
    Dilokthornsakul, Piyameth
    Pratoomsoot, Chayanin
    Chaiyakunapruk, Nathorn
    [J]. PHARMACOECONOMICS, 2014, 32 (08) : 801 - 813
  • [2] A COST-EFFECTIVENESS STUDY OF INTRAVENOUS IMMUNOGLOBULIN IN CHILDHOOD IDIOPATHIC THROMBOCYTOPENIA PURPURA PATIENTS WITH LIFE-THREATENING BLEEDING
    Sruamsiri, R.
    Dilokthornsakul, P.
    Chaiyakunapruk, N.
    Pratoomsoot, C.
    [J]. VALUE IN HEALTH, 2014, 17 (03) : A228 - A228
  • [3] Thrombotic thrombocytopenic purpura in childhood: An uncommon but life-threatening cause of thrombocytopenia
    Davis, Amanda
    Barnes, Chris
    [J]. JOURNAL OF PAEDIATRICS AND CHILD HEALTH, 2007, 43 (09) : 640 - 642
  • [4] INTRAVENOUS POLYVALENT HUMAN-IMMUNOGLOBULIN IN A CASE OF LIFE-THREATENING IMMUNE THROMBOCYTOPENIC PURPURA
    MANSBERG, R
    COUPLAND, WW
    [J]. MEDICAL JOURNAL OF AUSTRALIA, 1987, 146 (04) : 217 - 218
  • [5] Cost-effectiveness of eltrombopag vs intravenous immunoglobulin for the perioperative management of immune thrombocytopenia
    Kaur, Manraj N.
    Arnold, Donald M.
    Heddle, Nancy M.
    Cook, Richard J.
    Hsia, Cyrus
    Blostein, Mark
    Jamula, Erin
    Sholzberg, Michelle
    Lin, Yulia
    Kassis, Jeannine
    Larratt, Loree
    Tinmouth, Alan
    Carruthers, Julie
    Li, Na
    Liu, Yang
    Xie, Feng
    [J]. BLOOD ADVANCES, 2022, 6 (03) : 785 - 792
  • [6] COST-EFFECTIVENESS OF ALTERNATIVE MANAGEMENT STRATEGIES FOR LIFE-THREATENING ARRHYTHMIAS IN THE ESVEM TRIAL
    HLATKY, MA
    BOOTHROYD, DB
    JOHNSTONE, TM
    MARCUS, FI
    HAHN, E
    HARTZ, V
    MASON, JW
    [J]. CIRCULATION, 1994, 90 (04) : 43 - 43
  • [7] Long-term cost-effectiveness of alternative management strategies for patients with life-threatening ventricular arrhythmias
    Hlatky, MA
    Boothroyd, DB
    Johnstone, IM
    Marcus, FI
    Hahn, E
    Hartz, V
    Mason, JW
    [J]. JOURNAL OF CLINICAL EPIDEMIOLOGY, 1997, 50 (02) : 185 - 193
  • [8] Cost-effectiveness of treatment for acute childhood idiopathic thrombocytopenic purpura (ITP) - a systematic review
    Chen, M.
    Zhang, L-L
    Hu, M.
    Gao, J.
    Tong, R-S
    [J]. JOURNAL OF INTERNATIONAL MEDICAL RESEARCH, 2008, 36 (03) : 572 - 578
  • [9] Idiopathic thrombocytopenia purpura: Treatment patterns and an analysis of cost associated with intravenous immunoglobulin and anti-D therapy
    Simpson, KN
    Coughlin, CM
    Eron, J
    Bussel, JB
    [J]. SEMINARS IN HEMATOLOGY, 1998, 35 (01) : 58 - 64
  • [10] Cost-Effectiveness of Intravenous Immunoglobulin (IVIG) Treatment in Patients with B-Cell Immunodeficiencies
    Smirnova, I. N.
    Kosacheva, T. G.
    Kuzmenko, N. B.
    Shcherbina, A.
    Novichkova, G. A.
    [J]. JOURNAL OF CLINICAL IMMUNOLOGY, 2014, 34 : S301 - S301
12345